tiprankstipranks
Ocular Therapeutix Inc (OCUL)
:OCUL
US Market

Ocular Therapeutix (OCUL) Income Statement

Compare
1,411 Followers

Ocular Therapeutix Income Statement

Last quarter (Q3 2024), Ocular Therapeutix's total revenue was $15.43M, an increase of 3.18% from the same quarter last year. In Q3, Ocular Therapeutix's net income was $-36.49M. See Ocular Therapeutix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 58.44M$ 51.49M$ 43.52M$ 17.40M$ 4.23M
Gross Profit
$ 53.16M$ 46.95M$ 39.12M$ 15.32M$ 1.90M
Operating Expenses
$ 135.54M$ 125.61M$ 117.15M$ 78.17M$ 87.70M
Depreciation and Amortization
$ 2.98M$ 2.11M$ 2.42M$ 2.77M$ 2.53M
EBITDA
$ -66.42M$ -61.91M$ -75.62M$ -146.09M$ -77.74M
Operating Income
$ -82.38M$ -78.65M$ -78.04M$ -62.85M$ -85.80M
Other Income/Expenses
$ 1.65M$ 7.62M$ 71.48M$ -92.79M$ -570.00K
Pretax Income
$ -80.74M$ -71.04M$ -6.55M$ -155.64M$ -86.37M
Net Income
$ -80.74M$ -63.42M$ -10.80M$ -159.63M$ -89.94M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.09$ -0.83$ -0.14$ -2.63$ -1.99
Diluted EPS
$ -1.02$ -0.83$ -0.13$ -2.63$ -1.99
Weighted Average Shares Outstanding
79.83M 76.88M 76.39M 60.75M 45.27M
Weighted Average Shares Outstanding (Diluted)
85.60M 76.88M 82.16M 60.75M 45.27M
Currency in USD

Ocular Therapeutix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis